Navigation Links
IMPAKT Breast Cancer Conference press program
Date:5/6/2010

Press releases (embargo: 6 May, 16:45 CEST)

J. Hicks, USA
Genome breakthrough allows scientists to identify and profile tumor cells from very small samples
Researchers have developed a powerful new technique for analyzing the genome of single tumor cells. The breakthrough allows them to study in fine detail the biology of how tumors develop.

S. Loi, BE
Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
An international team of researchers has discovered molecular evidence that may explain why some women with HER2 over-expressing breast cancer do not respond to drugs designed to target this important molecule.

B. Haine-Kains, USA
Simple gene test identifies clinically important sub-types of breast cancer
A simple genetic test that uses just three genes is among the most effective means of classifying breast cancer into sub-types.

A. Giordano, USA
Survival in metastatic breast cancer directly linked to circulating tumor cells
A new study of metastatic breast cancer shows that the number of circulating tumor cells patients have in their blood directly correlates with the length of their survival.

The full conference program is available at http://www.esmo.org/events/breast-2010-impakt/program.html

Press conference

Thursday, 06/05 at 12:00-13:00 (CEST)

Hosts:
Dr Martine Piccart, Head of Chemotherapy Unit, Jules Bordet Institute in Brussels, IMPAKT Co-Founder
Dr Angelo Di Leo, Head of Medical Oncology Unit, Department of Oncology, Hospital of Prato, Italy, IMPAKT2010 Co-Chair
Dr Christos Sotiriou, Head of Functional Genomics & Translational Research Unit, Jules Bordet Institute in Brussels, IMPAKT2010 Co-Chair

Topics:

  • The impact of methodology in biomarkers research and validation
  • Translational research impact on the next decade
  • Impact of neo-adjuvant trial results in the future treatment practice


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
2. Simple gene test identifies clinically important subtypes of breast cancer
3. Survival in metastatic breast cancer directly linked to circulating tumor cells
4. Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds
5. Broccoli May Help Battle Breast Cancer
6. Edgy, Sassy And Informative: New Website for Breast Cancer Survivors To Get Real About Their 'New Normal'
7. Whole body MRI is highly accurate in the early detection of breast cancer metastases
8. PMH cancer researchers link ovarian hormone to breast stem cells growth
9. Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research
10. Aggressive Action Urged When Evaluating Breast Lesions
11. Indeterminate breast lesions found in high-risk patients should be evaluated aggressively to exclude malignancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: